NEPH

SEC source: 0000914190-17-000261 · edgar.xml · nonDerivative · entry 1

Astor Andrew · CIK 0001698052 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 186,709

SEC source: 0000914190-17-000167 · edgar.xml · nonDerivative · entry 1

Evans Daron · CIK 0001411726 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 613,378

F1 · balance_after: Includes 9,165 shares of restricted stock that vest on June 14, 2017, 213,068 shares of restricted stock that vest on June 23, 2017 and 17,756 shares of restricted stock that vest on September 30, 2017.

SEC source: 0000914190-17-000167 · edgar.xml · nonDerivative · entry 3

Evans Daron · CIK 0001411726 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · By UTMA #2

Disclosed balance after: 49,166

SEC source: 0000914190-17-000167 · edgar.xml · nonDerivative · entry 2

Evans Daron · CIK 0001411726 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · By UTMA #1

Disclosed balance after: 51,666

SEC source: 0000914190-17-000160 · edgar.xml · nonDerivative · entry 2

Evans Daron · CIK 0001411726 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 609,417

F1 · balance_after: Includes 9,165 shares of restricted stock that vest on June 14, 2017, 213,068 shares of restricted stock that vest on June 23, 2017 and 17,756 shares of restricted stock that vest on September 30, 2017.

SEC source: 0000914190-17-000160 · edgar.xml · nonDerivative · entry 1

Evans Daron · CIK 0001411726 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 601,917

F1 · balance_after: Includes 9,165 shares of restricted stock that vest on June 14, 2017, 213,068 shares of restricted stock that vest on June 23, 2017 and 17,756 shares of restricted stock that vest on September 30, 2017.

SEC source: 0000914190-17-000145 · edgar.xml · derivative · entry 4

Astor Andrew · CIK 0001698052 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 209,355

Underlying: Common Stock · 209,355 shares

Expires 2017-05-01

F3 · derivative.exercise_date: On 5/1/17, the Reporting Person was granted an option to purchase up to 418,709 shares of common stock of the Company. 12.5% of the shares subject to the option (relating to a total of 52,339 shares) vest on 5/1/18; 37.5% of the shares subject to the option (relating to a total of 157,016 shares) vest quarterly in 12 equal amounts, commencing on 7/1/18; 10% of the shares subject to the option (relating to a total of 41,871 shares) will vest, if ever, on the February 1st following the Company's first completed fiscal year in which annual revenue exceeds (continued)

F4 · derivative.exercise_date: $6,000,000; 20% of the shares subject to the option (relating to a total of 83,742 shares) will vest, if ever, on the February 1st following the Company's first completed fiscal year in which annual revenue exceeds $10,000,000; and 20% (relating to a total of 83,742 shares) will vest, if ever, upon approval of listing of the Company's common stock on the NASDAQ Stock Market, New York Stock Exchange or such other national securities exchange approved by the Board.

SEC source: 0000914190-17-000153 · edgar.xml · derivative · entry 2

Astor Andrew · CIK 0001698052 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 209,355

Underlying: Common Stock · 209,355 shares

Expires 2027-05-01

F1 · derivative.exercise_date: On 5/1/17, the Reporting Person was granted an option to purchase up to 418,709 shares of common stock of the Company. 12.5% of the shares subject to the option (relating to a total of 52,339 shares) vest on 5/1/18; 37.5% of the shares subject to the option (relating to a total of 157,016 shares) vest quarterly in 12 equal amounts, commencing on 7/1/18; 10% of the shares subject to the option (relating to a total of 41,871 shares) will vest, if ever, on the February 1st following the Company's first completed fiscal year in which annual revenue exceeds (continued)

F2 · derivative.exercise_date: $6,000,000; 20% of the shares subject to the option (relating to a total of 83,742 shares) will vest, if ever, on the February 1st following the Company's first completed fiscal year in which annual revenue exceeds $10,000,000; and 20% (relating to a total of 83,742 shares) will vest, if ever, upon approval of listing of the Company's common stock on the NASDAQ Stock Market, New York Stock Exchange or such other national securities exchange approved by the Board.

F3 · derivative.expiration_date: This amendment is being filed solely to correct the expiration date.

SEC source: 0000914190-17-000117 · edgar.xml · nonDerivative · entry 1

Evans Daron · CIK 0001411726 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 579,417

F1 · shares: On March 31, 2017, the Company granted 17,756 shares of restricted stock (the "Restricted Stock") to the Reporting Person in satisfaction of previously-deferred base salary. The Restricted Stock was granted under the Company's 2015 Equity Incentive Plan. The Restricted Stock vests six months following the grant date.

F2 · balance_after: Includes 9,165 shares of restricted stock that vest on June 14, 2017, 213,068 shares of restricted stock that vest on June 23, 2017 and 17,756 shares of restricted stock that vest on September 30, 2017.

SEC source: 0000914190-17-000113 · edgar.xml · derivative · entry 3

Astor Andrew · CIK 0001698052 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 166,666

Underlying: Common Stock · 166,666 shares

Expires 2022-03-17

F1 · price: The reported securities have a purchase price of $0.30 per share of Common Stock. In addition, the reporting person received a Warrant to purchase a number of shares of Common Stock equal to 100% of the number of shares of Common Stock otherwise purchased. The reporting person purchased 166,666 shares of Common Stock and was issued a related Warrant to acquire up to 166,666 shares of Common Stock.

SEC source: 0000914190-17-000113 · edgar.xml · nonDerivative · entry 1

Astor Andrew · CIK 0001698052 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 166,666

F1 · price: The reported securities have a purchase price of $0.30 per share of Common Stock. In addition, the reporting person received a Warrant to purchase a number of shares of Common Stock equal to 100% of the number of shares of Common Stock otherwise purchased. The reporting person purchased 166,666 shares of Common Stock and was issued a related Warrant to acquire up to 166,666 shares of Common Stock.

SEC source: 0000914190-17-000112 · edgar.xml · derivative · entry 10

Evans Daron · CIK 0001411726 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · By UTMA #2

Disclosed balance after: 41,666

Underlying: Common Stock · 41,666 shares

Expires 2022-03-17

F2 · price: The reported securities have a purchase price of $0.30 per share of Common Stock. In addition, the reporting person indirectly received a Warrant to purchase a number of shares of Common Stock equal to 100% of the number of shares of Common Stock otherwise purchased. The reporting person indirectly purchased 41,666 shares of Common Stock and was indirectly issued a related Warrant to acquire up to 41,666 shares of Common Stock.

SEC source: 0000914190-17-000112 · edgar.xml · derivative · entry 9

Evans Daron · CIK 0001411726 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · By UTMA #1

Disclosed balance after: 41,666

Underlying: Common Stock · 41,666 shares

Expires 2022-03-17

F2 · price: The reported securities have a purchase price of $0.30 per share of Common Stock. In addition, the reporting person indirectly received a Warrant to purchase a number of shares of Common Stock equal to 100% of the number of shares of Common Stock otherwise purchased. The reporting person indirectly purchased 41,666 shares of Common Stock and was indirectly issued a related Warrant to acquire up to 41,666 shares of Common Stock.

SEC source: 0000914190-17-000112 · edgar.xml · nonDerivative · entry 3

Evans Daron · CIK 0001411726 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · By UTMA #2

Disclosed balance after: 41,666

F2 · price: The reported securities have a purchase price of $0.30 per share of Common Stock. In addition, the reporting person indirectly received a Warrant to purchase a number of shares of Common Stock equal to 100% of the number of shares of Common Stock otherwise purchased. The reporting person indirectly purchased 41,666 shares of Common Stock and was indirectly issued a related Warrant to acquire up to 41,666 shares of Common Stock.

SEC source: 0000914190-17-000112 · edgar.xml · nonDerivative · entry 2

Evans Daron · CIK 0001411726 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · By UTMA #1

Disclosed balance after: 41,666

F2 · price: The reported securities have a purchase price of $0.30 per share of Common Stock. In addition, the reporting person indirectly received a Warrant to purchase a number of shares of Common Stock equal to 100% of the number of shares of Common Stock otherwise purchased. The reporting person indirectly purchased 41,666 shares of Common Stock and was indirectly issued a related Warrant to acquire up to 41,666 shares of Common Stock.

SEC source: 0000914190-17-000055 · edgar.xml · derivative · entry 1

Astor Andrew · CIK 0001698052 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 289,785

Underlying: Common Stock · 289,785 shares

Expires 2027-02-13

F1 · derivative.exercise_date: On 2/13/17, the Reporting Person was granted an option to purchase up to 579,571 shares of common stock of the Company. 12.5% of the shares subject to the option (relating to a total of 72,446 shares) vest on 2/13/18; 37.5% of the shares subject to the option (relating to a total of 217,339 shares) vest quarterly in 12 equal amounts, commencing on 5/13/18; 20% of the shares subject to the option (relating to a total of 115,914 shares) will vest, if ever, upon approval of listing of the Company's common stock on the NASDAQ Stock Market, New York Stock Exchange or such other national securities exchange approved by the Board; 10% of the shares subject to the option (relating to a total of 57,957 shares) will vest, if ever, on the February 1st following the Company's first completed fiscal year in which annual revenue exceeds $6,000,000; (continued)

F2 · derivative.exercise_date: and 20% of the shares subject to the option (relating to a total of 115,914 shares) will vest, if ever, on the February 1st following the Company's first completed fiscal year in which annual revenue exceeds $10,000,000.

SEC source: 0000914190-16-000993 · edgar.xml · nonDerivative · entry 1

Evans Daron · CIK 0001411726 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 561,661

F1 · shares: On December 23, 2016, the Company granted 213,068 shares of restricted stock (the "Restricted Stock") to the Reporting Person in lieu of a $60,000 cash bonus. The Restricted Stock was granted under the Company's 2015 Equity Incentive Plan. The Restricted Stock vests six months following the grant date.

SEC source: 0000914190-16-000989 · edgar.xml · nonDerivative · entry 1

Evans Daron · CIK 0001411726 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 348,593

F1 · shares: On December 14, 2016, the Company granted 9,165 shares of restricted stock (the "Restricted Stock") to the Reporting Person in satisfaction of previously-deferred base salary. The Restricted Stock was granted under the Company's 2015 Equity Incentive Plan. The Restricted Stock vests six months following the grant date.

SEC source: 0000914190-16-000930 · edgar.xml · nonDerivative · entry 1

Evans Daron · CIK 0001411726 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 339,428

SEC source: 0000914190-16-000921 · edgar.xml · nonDerivative · entry 2

Evans Daron · CIK 0001411726 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 335,359

SEC source: 0000914190-16-000921 · edgar.xml · nonDerivative · entry 1

Evans Daron · CIK 0001411726 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 329,339

SEC source: 0000914190-16-000918 · edgar.xml · nonDerivative · entry 2

Evans Daron · CIK 0001411726 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 324,739

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.315 to $0.33 inclusive. The reporting person undertakes to provide Nephros, Inc., any security holder of Nephros, Inc., or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

SEC source: 0000914190-16-000918 · edgar.xml · nonDerivative · entry 1

Evans Daron · CIK 0001411726 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 284,140